| Glenn Harper, MD | |
|
825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 | |
| (610) 527-1165 | |
| (610) 527-6611 |
| Full Name | Glenn Harper |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 39 Years |
| Location | 825 Old Lancaster Rd, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679578629 | NPI | - | NPPES |
| 0014650010009 | Medicaid | PA | |
| 0014650010015 | Medicaid | PA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Main Line Health Home Care & Hospice - Home Health | Radnor, PA | Home health agency |
| Bryn Mawr Hospital | Bryn mawr, PA | Hospital |
| Main Line Hospital Lankenau | Wynnewood, PA | Hospital |
| Paoli Hospital | Paoli, PA | Hospital |
| Riddle Memorial Hospital | Media, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bryn Mawr Medical Specialists Association | 4183610934 | 94 |
News Archive
The Center for Resilient Design at New Jersey Institute of Technology, part of the university's College of Architecture and Design, has received a two-year grant from the New Jersey Sea Grant Consortium to develop ways to protect ecosystems and their surrounding communities from flood waters.
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators.
Immunotec Inc. announces that Nova Southeastern University (NSU) in Florida is conducting a study to determine the effects of Immunocal on the behaviours of children with autism spectrum disorder.
› Verified 7 days ago
| Entity Name | Bryn Mawr Medical Specialists Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841226099 PECOS PAC ID: 4183610934 Enrollment ID: O20040426000467 |
News Archive
The Center for Resilient Design at New Jersey Institute of Technology, part of the university's College of Architecture and Design, has received a two-year grant from the New Jersey Sea Grant Consortium to develop ways to protect ecosystems and their surrounding communities from flood waters.
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators.
Immunotec Inc. announces that Nova Southeastern University (NSU) in Florida is conducting a study to determine the effects of Immunocal on the behaviours of children with autism spectrum disorder.
› Verified 7 days ago
| Entity Name | Bmmsa Heart & Vascular Center Of The Main Line |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1578222758 PECOS PAC ID: 9931591740 Enrollment ID: O20220127001639 |
News Archive
The Center for Resilient Design at New Jersey Institute of Technology, part of the university's College of Architecture and Design, has received a two-year grant from the New Jersey Sea Grant Consortium to develop ways to protect ecosystems and their surrounding communities from flood waters.
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators.
Immunotec Inc. announces that Nova Southeastern University (NSU) in Florida is conducting a study to determine the effects of Immunocal on the behaviours of children with autism spectrum disorder.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Glenn Harper, MD 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 Ph: (610) 527-1165 | Glenn Harper, MD 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010-3231 Ph: (610) 527-1165 |
News Archive
The Center for Resilient Design at New Jersey Institute of Technology, part of the university's College of Architecture and Design, has received a two-year grant from the New Jersey Sea Grant Consortium to develop ways to protect ecosystems and their surrounding communities from flood waters.
Using a rodent model of epilepsy, researchers found one of the body's own neurotransmitters released during seizures, glutamate, turns on a signaling pathway in the brain that increases production of a protein that could reduce medication entry into the brain.
Massachusetts General Hospital investigators may have uncovered a novel mechanism behind the ability of obesity to promote cancer progression. In their report published online in the journal Clinical Cancer Research, the research team describes finding an association between obesity and an overabundance of a factor called PlGF (placental growth factor) and that PlGF's binding to its receptor VEGFR-1, which is expressed on immune cells within tumors, promotes tumor progression.
Thousands of patients with an advanced form of lung cancer that carries a specific dysfunctional gene are likely to fare better if treated with a targeted therapy than with traditional chemotherapy, report Dana-Farber Cancer Institute researchers and a team of international collaborators.
Immunotec Inc. announces that Nova Southeastern University (NSU) in Florida is conducting a study to determine the effects of Immunocal on the behaviours of children with autism spectrum disorder.
› Verified 7 days ago
Dr. Sameer Gupta, MD, MPH Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Kellie Ann Matson, PA-C Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-3000 | |
John Steers, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-1165 Fax: 610-527-6611 | |
Dr. Clarke U. Piatt, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Francis P. Day, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Robert R Atkins, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 825 Old Lancaster Rd, Suite 320, Bryn Mawr, PA 19010 Phone: 610-527-3800 Fax: 610-527-0334 | |
Dr. Sophia Moldavsky, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 830 Old Lancaster Rd Ste 206, Bryn Mawr, PA 19010 Phone: 610-525-8110 |